Next Article in Journal
Therapeutic Effect of Bone Marrow Mesenchymal Stem Cells on Laser-Induced Retinal Injury in Mice
Next Article in Special Issue
Novel Aspects of the Liver Microenvironment in Hepatocellular Carcinoma Pathogenesis and Development
Previous Article in Journal
Maize ZmRACK1 Is Involved in the Plant Response to Fungal Phytopathogens
Previous Article in Special Issue
Molecular Mechanisms of Liver Fibrosis in HIV/HCV Coinfection
Int. J. Mol. Sci. 2014, 15(6), 9360-9371; doi:10.3390/ijms15069360
Review

MicroRNA Function in the Profibrogenic Interplay upon Chronic Liver Disease

1
, 1
, 1
, 1,2,3
 and 1,2,*
Received: 16 March 2014; in revised form: 6 May 2014 / Accepted: 12 May 2014 / Published: 27 May 2014
(This article belongs to the collection Molecular Mechanisms of Human Liver Diseases)
View Full-Text   |   Download PDF [476 KB, updated 19 June 2014; original version uploaded 19 June 2014]   |   Browse Figures
Abstract: In chronic liver disease leading to fibrosis, hepatic stellate cells (HSC) differentiate into myofibroblasts. Myofibroblastic HSC have taken center stage during liver fibrogenesis, due to their remarkable synthesis of extracellular matrix proteins, their secretion of profibrogenic mediators and their contribution to hypertension, due to elevated contractility. MicroRNAs (miRNAs) are small, noncoding RNA molecules of 19–24 nucleotides in length. By either RNA interference or inhibition of translational initiation and elongation, each miRNA is able to inhibit the gene expression of a wide panel of targeted transcripts. Recently, it was shown that altered miRNA patterns after chronic liver disease highly affect the progression of fibrosis by their potential to target the expression of extracellular matrix proteins and the synthesis of mediators of profibrogenic pathways. Here, we underline the role of miRNAs in the interplay of the profibrogenic cell communication pathways upon myofibroblastic differentiation of hepatic stellate cells in the chronically injured liver.
Keywords: liver fibrosis; myofibroblastic transition; TGF-β; miRNA liver fibrosis; myofibroblastic transition; TGF-β; miRNA
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Huang, J.; Yu, X.; Fries, J.W.U.; Zhang, L.; Odenthal, M. MicroRNA Function in the Profibrogenic Interplay upon Chronic Liver Disease. Int. J. Mol. Sci. 2014, 15, 9360-9371.

AMA Style

Huang J, Yu X, Fries JWU, Zhang L, Odenthal M. MicroRNA Function in the Profibrogenic Interplay upon Chronic Liver Disease. International Journal of Molecular Sciences. 2014; 15(6):9360-9371.

Chicago/Turabian Style

Huang, Jia; Yu, Xiaojie; Fries, Jochen W.U.; Zhang, Li'ang; Odenthal, Margarete. 2014. "MicroRNA Function in the Profibrogenic Interplay upon Chronic Liver Disease." Int. J. Mol. Sci. 15, no. 6: 9360-9371.


Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert